Earnings call transcript: B&C Speakers H1 2026 sales fall as margins hold up

B&C Speakers reported H1 2026 revenue of €47 million, down 7% year over year, but maintained EBITDA above €9 million and an adjusted EBITDA margin near 20%, while free cash flow reached €5.1 million. Net profit increased materially as lower foreign-exchange losses offset softer demand, and shares fell 1.74% to $11.30. Management expects key OEM customers L-Acoustics and d&b audiotechnik, which represent roughly 30% of sales, to restore orders to 2025 levels or better from September, but China, North American retail/DIY demand and Middle East recovery remain material uncertainties.

Analysis

BEC is transitioning from a volume-sensitive component supplier toward a more operationally leveraged recovery story, but the earnings-quality signal is mixed. Margin defense is encouraging, yet the improvement in bottom-line profitability appears materially influenced by financial-result normalization rather than a durable acceleration in underlying demand. The market will likely assign little credit for this until order recovery converts into shipments and working-capital intensity stops rising.

The key second-order risk is that inventory accumulation and capacity spending are being undertaken before the demand recovery is independently visible. If European OEM schedules hold, prebuilt inventory should improve service levels and permit strong incremental margins in Q4 and 2027; if schedules slip, inventory becomes a cash-conversion drag and the company’s dividend-plus-capex posture could constrain balance-sheet flexibility. Customer concentration makes this especially binary: a recovery at the two large professional-audio OEMs can create rapid operating leverage, while another postponement would undermine the "temporary" slowdown thesis.

China is not merely a regional demand issue; counterfeit substitution can pressure the long-term value of BEC's engineering and brand premium, potentially shifting growth toward lower-margin locally produced offerings. Conversely, the company’s China-made Eminence Pro initiative could become a strategic hedge if it gains channel traction, though it also risks cannibalizing higher-value European production. North American DIY weakness is less important to the core OEM thesis but is a useful read-through on lower-income discretionary demand and should not be assumed to rebound with professional-event spending.

The share-price weakness may be underappreciating normalized-margin upside if September-October orders translate into Q4 revenue, but management commentary is not sufficient evidence on its own. With no external consensus benchmark and likely limited liquidity, this is a confirmation trade rather than an immediate fundamental long: the next reporting period must demonstrate sequential revenue conversion, stable inventory days, and no deterioration in gross margin.

Key Decisions for Investors

• Maintain BEC on a watchlist rather than initiate at the open; require evidence that September-October customer orders convert into Q4 sales and that inventory growth moderates. A position becomes actionable on confirmed sequential revenue recovery with EBITDA margin sustained near current levels.
• For a small-cap/value sleeve, consider a starter long in BEC only after post-results liquidity is assessed, sized modestly given customer concentration and uncertain China exposure. Upside case is a rerating on 2027 operating leverage; thesis fails if Q4 revenue remains below prior-year levels or management reduces its recovery outlook.
• Do not underwrite the dividend as the primary return driver while inventory, automation and production-line spending are increasing. Monitor net debt/working-capital movement at the next result; a meaningful balance-sheet deterioration despite improved orders would signal that cash generation is less durable than headline operating cash flow suggests.
• Use European professional-audio OEM order commentary as the highest-frequency catalyst over the next 1-3 months. Any renewed order deferral from major customers, or evidence that China counterfeit competition is affecting Western OEM system volumes, should invalidate a long thesis before waiting for annual results.